Captrust Financial Advisors Atri Cure, Inc. Transaction History

Captrust Financial Advisors

  • $43.1 Billion
  • Q2 2025

A detailed history of Captrust Financial Advisors transactions in Atri Cure, Inc. stock. As of the latest transaction made, Captrust Financial Advisors holds 7,299 shares of ATRC stock, worth $252,180. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,299
Previous 6,701 8.92%
Holding current value
$252,180
Previous $216,000 10.65%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
BUY
$29.07 - $34.94 $17,383 - $20,894
598 Added 8.92%
7,299 $239,000
Q1 2025

May 14, 2025
SELL
$30.4 - $42.4 $44,840 - $62,540
-1,475 Reduced 18.04%
6,701 $216,000
Q4 2024

Feb 14, 2025
SELL
$27.02 - $38.2 $405 - $573
-15 Reduced 0.18%
8,176 $249,000
Q3 2024

Nov 14, 2024
BUY
$20.34 - $29.5 $166,604 - $241,634
8,191 New
8,191 $229,000
Q1 2024

May 15, 2024
SELL
$28.21 - $37.78 $257,105 - $344,326
-9,114 Reduced 55.96%
7,173 $218,000
Q4 2023

Feb 14, 2024
SELL
$32.99 - $43.25 $321,883 - $421,990
-9,757 Reduced 37.46%
16,287 $581,000
Q3 2023

Nov 14, 2023
BUY
$41.12 - $57.73 $3,371 - $4,733
82 Added 0.32%
26,044 $1.14 Million
Q2 2023

Aug 14, 2023
BUY
$40.44 - $49.6 $823,722 - $1.01 Million
20,369 Added 364.19%
25,962 $1.28 Million
Q1 2023

May 15, 2023
BUY
$35.87 - $47.22 $3,156 - $4,155
88 Added 1.6%
5,593 $231,000
Q4 2022

Feb 15, 2023
SELL
$33.48 - $47.45 $2,678 - $3,796
-80 Reduced 1.43%
5,505 $244,000
Q3 2022

Nov 16, 2022
SELL
$38.25 - $52.62 $42,151 - $57,987
-1,102 Reduced 16.48%
5,585 $218,000
Q2 2022

Aug 16, 2022
BUY
$35.1 - $66.01 $46,051 - $86,605
1,312 Added 24.41%
6,687 $273,000
Q1 2022

May 16, 2022
SELL
$57.43 - $71.39 $96,482 - $119,935
-1,680 Reduced 23.81%
5,375 $353,000
Q4 2021

Feb 14, 2022
BUY
$63.4 - $87.14 $285,997 - $393,088
4,511 Added 177.32%
7,055 $491,000
Q3 2021

Nov 16, 2021
BUY
$69.28 - $84.46 $9,352 - $11,402
135 Added 5.6%
2,544 $177,000
Q2 2021

Aug 16, 2021
BUY
$64.13 - $80.18 $96,323 - $120,430
1,502 Added 165.6%
2,409 $191,000
Q1 2021

May 17, 2021
SELL
$53.79 - $66.98 $193,267 - $240,659
-3,593 Reduced 79.84%
907 $59,000
Q2 2020

Aug 14, 2020
BUY
$31.78 - $51.19 $143,010 - $230,355
4,500 New
4,500 $204,000
Q4 2019

Feb 14, 2020
SELL
$24.06 - $32.51 $108,270 - $146,295
-4,500 Closed
0 $0
Q2 2019

Aug 13, 2019
BUY
$26.85 - $30.74 $120,825 - $138,330
4,500 New
4,500 $134,000

Others Institutions Holding ATRC

# of Institutions
224
Shares Held
52.2M
Call Options Held
33.5K
Put Options Held
0
View Full List

About AtriCure, Inc.

ATRC Quotes by TradingView
  • Ticker ATRC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 46,424,700
  • Market Cap $1.6B
  • Description
  • AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...
More about ATRC
Track This Portfolio

Track Captrust Financial Advisors Portfolio

Follow Captrust Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email